Which is more profitable, McKesson or Medtronic?

Medtronic keeps more of every sale as profit.

Which grows faster, McKesson or Medtronic?

McKesson grew its sales faster in recent years.

Which is cheaper, McKesson or Medtronic?

McKesson costs less for each unit of yearly profit (lower P/E).

Which has less debt, McKesson or Medtronic?

McKesson would need fewer years of earnings to pay off its debt.

McKessonMCKvs

MedtronicMDT

McKesson vs Medtronic stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

McKesson grows faster, is cheaper for its profits and has less debt. Medtronic is more profitable.

Side by side

	McKesson	Medtronic
	$127 billion	$132 billion
	1.2%	13.2%
	+11.1%	+3.8%
	26.7×	27.4×
	0.6 years	2.7 years
	81.1%	7.2%
	0.4%	3.5%

Open McKesson Open Medtronic

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: McKesson vs Merck & · McKesson vs Roche · McKesson vs UnitedHealth · McKesson vs AbbVie · Medtronic vs Novo Nordisk · Medtronic vs Regeneron Pharmaceuticals · Medtronic vs Roche · Medtronic vs Thermo Fisher Scientific